Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe von FELDMAN, H. H, DOODY, R. S, BREAZNA, A, KIVIPELTO, M, SPARKS, D. L, WATERS, D. D, JONES, R. W, SCHWAM, E, SCHINDLER, R, HEY-HADAVI, J, DEMICCO, D. A

Volltext

Genome-wide association study of genetic determinants of LDL-c response to atorvastatin therapy: importance of Lp(a) von Deshmukh, HA, Colhoun, HM, Johnson, T, McKeigue, PM, Betteridge, DJ, Durrington, PN, Fuller, JH, Livingstone, S, Charlton-Menys, V, Neil, A, Poulter, N, Sever, P, Shields, DC, Stanton, AV, Chatterjee, A, Hyde, C, Calle, RA, DeMicco, DA, Trompet, S, Postmus, I, Ford, I, Jukema, JW, Caulfield, M, Hitman, GA

Volltext

Relationship of high-density lipoprotein cholesterol with renal function in patients treated with atorvastatin von Ong, KL, Waters, DD, Fayyad, R, Vogt, L, Melamed, S, DeMicco, DA, Rye, KA, Barter, PJ

Volltext bestellen

High plasma FGF21 levels predicts major cardiovascular events in patients treated with atorvastatin (from the Treating to New Targets [TNT] Study) von Ong, KL, Hui, N, Januszewski, AS, Kaakoush, NO, Xu, A, Fayyad, R, DeMicco, DA, Jenkins, AJ, Keech, AC, Waters, DD, Barter, PJ, Rye, KA

Volltext bestellen

Effect of change in body weight on incident diabetes mellitus in patients with stable coronary artery disease treated with atorvastatin (from the Treating to New Targets Study) von Ong, KL, Waters, DD, Messig, M, Demicco, DA, Rye, KA, Barter, PJ

Volltext bestellen

Abstract LB061: Proteomic-based stemness score measure oncogenic dedifferentiation and enable the identification of druggable targets von Malta, Tathiane M., Kołodziejczak, Iga, Simões, Renan, Colaprico, Antonio, Storrs, Erik, Petralia, Francesca, da v Leprevost, Felipe, Segura, Rossana L., Demicco, Elizabeth, Lazar, Alexander J., Ma, Weiping, Pugliese, Pietro, Ceccarelli, Michele, Kamińska, Bozena, Nesvizhski, Alexey I., Zhang, Bing, Rodriguez, Henry, Mesri, Mehdi, Robles, Ana I., Ding, Li, Wiznerowicz, Maciej

Volltext

RETRACTED: Plasma PCSK9 Levels and Clinical Outcomes in the TNT (Treating to New Targets) Trial von Huijgen, Roeland, MD, Boekholdt, S. Matthijs, MD, PhD, Arsenault, Benoit J., PhD, Bao, Weihang, PhD, Davaine, Jean-Michel, MD, Tabet, Fatiha, PhD, Petrides, Francine, BSc, Rye, Kerry-Anne, PhD, DeMicco, David A., PharmD, Barter, Philip J., MD, PhD, Kastelein, John J.P., MD, PhD, Lambert, Gilles, PhD

Volltext

The effect of atorvastatin therapy on tumour necrosis factor-α and vascular adhesion molecules in patients with type 2 diabetes mellitus with no prior history of coronary heart dis... von Soedamah-Muthu, Sabita S, Charlton-Menys, Val, Bao, Weihang, Schalkwijk, Casper, Da Stehouwer, Coen, Colhoun, Helen M, Betteridge, D John, Durrington, Paul N, Hitman, Graham A, Neil, H Andrew W, Livingstone, Shona J, Fuller, John H, Demicco, David A, Preston, Gregory M

Volltext